Glossary · PeptideU · 7 min read

What Is KAHA Ligation? Definition and What Research Reports

The short answer

KAHA ligation stands for α-ketoacid–hydroxylamine ligation: a chemoselective reaction that joins a peptide carrying a C-terminal α-ketoacid to a peptide carrying an N-terminal hydroxylamine, forming a new amide bond with loss of carbon dioxide. It is a laboratory synthesis method, not a substance that is administered. Published reviews, protocols and case studies report its use to assemble proteins such as SUMO2/3, nitrophorin 4, ubiquitin and other polypeptides from separately made fragments, using different hydroxylamine building blocks to control the junction residue.

Definition

KAHA ligation — short for α-ketoacid–hydroxylamine ligation — is a chemoselective, amide-bond-forming reaction in which a peptide bearing a C-terminal α-ketoacid is joined to a second peptide bearing an N-terminal hydroxylamine, generating a new amide (peptide) bond with loss of carbon dioxide. It is a method, not a molecule: the term names a chemical transformation that researchers use to assemble long peptides and small proteins from shorter fragments made by solid-phase synthesis or recombinant expression. A review in Accounts of Chemical Research described the reaction as a chemoselective ligation for chemical protein synthesis that operates on unprotected peptide fragments without external coupling reagents (PMID 28849903).

What Class of Chemistry Is Involved, and Where the Term Comes From

KAHA ligation belongs to the family of chemoselective amide-forming ligations in synthetic organic and peptide chemistry. Two functional groups do the work:

The term originates entirely in the chemistry literature. It appears in synthesis papers, mechanistic studies, and step-by-step protocols — for example a Nature Protocols article describing protein chemical synthesis by α-ketoacid–hydroxylamine ligation (PMID 27227514). Because KAHA ligation is a bench technique, it has no dose, no route of administration and no pharmacology of its own; the products it makes are the molecules that later become subjects of biological study. This page is for educational purposes only and is not medical advice; consult a licensed physician with any question about a medical condition or treatment.

How the Term Is Used in Peptide Research

In practice, researchers use "KAHA ligation" in three overlapping ways:

  1. As a synthesis strategy. A long target sequence is divided into two or more fragments at a chosen junction, each fragment is made separately, and the pieces are joined by the ligation. The Accounts of Chemical Research review presented this fragment-condensation logic as the basis for chemical protein synthesis with KAHA ligation (PMID 28849903).
  2. As a reaction name in mechanistic work. A study in Organic & Biomolecular Chemistry proposed a revised mechanism for the α-ketoacid–hydroxylamine amide-forming ligations (PMID 27924344).
  3. As shorthand for a junction residue. Because the hydroxylamine building block becomes part of the final sequence, papers frequently specify which residue the ligation forms — for instance a study reporting KAHA ligation at serine (PMID 26597397).

Building Blocks and the Residue Formed

Much of the published work on KAHA ligation concerns the hydroxylamine partner, because its structure determines what amino acid appears at the ligation site.

Reported building block or variantResidue or handle reported at the junctionSource
5-OxaprolineUsed as the standard cyclic hydroxylamine in described protein-synthesis proceduresPMID 34386958
(S)-4,4-Difluoro-5-oxaprolineReported to give aspartic acid–forming ligationsPMID 31840512
Serine-forming variantReported to place a serine residue at the ligation sitePMID 26597397
Aspartyl aldehyde–forming variantReported to leave an aldehyde as a synthetic handle for protein modification and purificationPMID 25474323
Cyclic hydroxylamines for native residuesReported in ligations forming native residues, applied to ubiquitin and tirzepatidePMID 40934092

Doing the math on a vial? The PeptideU app does reconstitution, units and dilution for you.

Try it free

What the Published Literature Reports

The literature on KAHA ligation is largely composed of synthesis demonstrations, methodological refinements and mechanistic analysis. Representative reports include the following.

Protein targets assembled by the reaction

Researchers reported the chemical synthesis of the 20 kDa heme protein nitrophorin 4 using α-ketoacid–hydroxylamine ligation (PMID 26346606). A separate study reported the traceless preparation of C-terminal α-ketoacids and applied the approach to the synthesis of SUMO2/3 (PMID 25244549). More recently, a Journal of the American Chemical Society report described cyclic hydroxylamines for native residue–forming peptide ligations and used them in the synthesis of ubiquitin and tirzepatide (PMID 40934092). Work in RSC Chemical Biology reported the chemical synthesis of the EPF family of plant cysteine-rich proteins together with late-stage dye attachment by chemoselective amide-forming ligations (PMID 36544577).

Methodological and mechanistic reports

A Nature Protocols article set out procedures for protein chemical synthesis by α-ketoacid–hydroxylamine ligation (PMID 27227514), and a later methods chapter described the same chemistry with 5-oxaproline (PMID 34386958). On the mechanistic side, the study in Organic & Biomolecular Chemistry reported a revised mechanism for the amide-forming step (PMID 27924344). Related chemoselective amide chemistry has also been examined: one study reported the synthesis and reactivities of monofluoro acylboronates in chemoselective amide bond–forming ligation with hydroxylamines (PMID 26566143), which is a distinct but adjacent reaction class that also pairs an acyl donor with a hydroxylamine.

Expanding the set of junction residues

A recurring theme in the published work is broadening which amino acid can sit at the ligation site. The study on (S)-4,4-difluoro-5-oxaproline reported aspartic acid–forming KAHA ligations (PMID 31840512); the serine-forming report addressed ligation at serine (PMID 26597397); and a JACS study reported ligations that form aspartyl aldehyde residues intended as synthetic handles for protein modification and purification (PMID 25474323). The 2025 cyclic-hydroxylamine report continued this line by describing native residue–forming ligations (PMID 40934092).

Limitations and Open Questions: What Studies Report

Because KAHA ligation is a chemistry method, the published limitations are synthetic rather than clinical. The reviewed literature frames fragment selection, the junction residue and the availability of suitable building blocks as the central practical constraints, which is why the review, protocol and methods papers devote space to how junctions are chosen and how the α-ketoacid and hydroxylamine partners are prepared (PMID 28849903, PMID 27227514). The continuing development of new hydroxylamine building blocks — aspartic acid–forming (PMID 31840512), serine-forming (PMID 26597397) and native residue–forming (PMID 40934092) — indicates that residue scope remained an active research question across these reports. Nothing in this literature addresses administration, dosing or human use of any product, and none of the cited work should be read as describing a therapy.

Tracking research? Log entries with dates, lots and notes — records, never plans.

Get the app

References

Frequently asked questions

What does KAHA stand for?

KAHA stands for α-ketoacid–hydroxylamine. The name describes the two reacting partners: a peptide with a C-terminal α-ketoacid and a peptide with an N-terminal hydroxylamine, which combine to form an amide bond. A review in Accounts of Chemical Research described the reaction as a chemoselective ligation used for chemical protein synthesis on unprotected peptide fragments (PMID 28849903).

Is KAHA ligation a peptide or a compound?

Neither. It is a chemical reaction used in the laboratory to join peptide fragments, so it has no dose, route or pharmacology of its own. Published work describes it as a synthesis method, including a Nature Protocols article that set out procedures for protein chemical synthesis by α-ketoacid–hydroxylamine ligation (PMID 27227514).

What proteins have researchers made using KAHA ligation?

Published examples include the 20 kDa heme protein nitrophorin 4, which researchers reported synthesising by α-ketoacid–hydroxylamine ligation (PMID 26346606), and SUMO2/3, reported alongside a traceless method for preparing C-terminal α-ketoacids (PMID 25244549). A 2025 study reported native residue–forming ligations applied to ubiquitin and tirzepatide (PMID 40934092).

What is 5-oxaproline in KAHA ligation?

5-Oxaproline is a cyclic hydroxylamine building block placed at the N-terminus of one fragment. A Methods in Molecular Biology chapter described chemoselective α-ketoacid–hydroxylamine ligations carried out with 5-oxaproline as a route to chemical protein synthesis (PMID 34386958). Related reports examined other building blocks, including a difluorinated version reported to give aspartic acid–forming ligations (PMID 31840512).

Which amino acids can sit at a KAHA ligation junction?

The hydroxylamine building block determines the junction residue, and expanding that scope has been an active research theme. Researchers reported ligation at serine (PMID 26597397), aspartic acid–forming ligations using (S)-4,4-difluoro-5-oxaproline (PMID 31840512), and cyclic hydroxylamines for native residue–forming ligations (PMID 40934092).

How is the KAHA ligation mechanism described in the literature?

The mechanism has been revisited as the chemistry matured. A study in Organic & Biomolecular Chemistry reported a revised mechanism for the α-ketoacid–hydroxylamine amide-forming ligations (PMID 27924344), and the Accounts of Chemical Research review placed the reaction within the broader set of chemoselective ligations used for chemical protein synthesis (PMID 28849903).

How does KAHA ligation differ from acylboron ligation?

Both are chemoselective amide-forming reactions that use a hydroxylamine partner, but the acyl donor differs. KAHA ligation uses an α-ketoacid (PMID 28849903), whereas a separate study reported the synthesis and reactivities of monofluoro acylboronates in chemoselective amide bond–forming ligation with hydroxylamines (PMID 26566143). One report also used chemoselective amide-forming ligations for late-stage dye attachment to plant cysteine-rich proteins (PMID 36544577).

The PeptideU app

Track it. Calculate it. Actually understand it.

Research trackerLog every entry with dates, lots and notes — records, never plans.
CalculatorsReconstitution, units and dilution maths without the guesswork.
The UniversityEvery compound explained, evidence-graded, cited to the literature.
Get started freePeptideU Premium — $9.99/mo for the full curriculum, advanced tracking & giveaways

Download on theApp Store — Free

References

  1. PMID 28849903
  2. PMID 27227514
  3. PMID 34386958
  4. PMID 27924344
  5. PMID 31840512
  6. PMID 26597397
  7. PMID 25474323
  8. PMID 25244549
  9. PMID 26346606
  10. PMID 40934092
  11. PMID 36544577
  12. PMID 26566143
Keep learning
18+ · Educational purposes only
This page summarises published research for education — it is not medical advice, and nothing here is a recommendation to use, purchase, or dose any substance. Study parameters described are what researchers reported, not instructions. Consult a qualified clinician before any health decision.
Learn it properly — freeGet the PeptideU app